Carbone, that is still open, not dded by yourself
""""Team, carbone??...google the msft news...i will display it middle of the week
carbone, that would be something for you to add productively to ourselves, the team....""""
Carbone, fyi, In case you fail to answer that simple dd request it will be done by somebody else....
Oil prices are up about 15% from November 8, this was not in surprice to me and was signalled by :
** I Know First system** last November.
IMO it is just a very beginning and crude oil prices are on the way to the North.
Solar Sector will also benefit from crude oil price rally.
Credit to green_lanterns_11 for recalling the following announcement.
Microvision scores retinal scanning display order from Telesensory
September 22, 2000
Virtual retinal display manufacturer Microvision Inc. (Bothell, Washington) has received a purchase agreement for Nomad wearable displays from Telesensory (Sunnyvale, California), which focuses on developing products to assist people with low vision. Telesensory will use the Nomads as a low vision device intended to improve the ability of people with low vision to read printed material.
Telesensory has agreed to an initial purchase of ten Nomad systems, and will immediately begin evaluations for a 90-day period with Microvision's current prototype display at selected private and public low vision clinics. According to Telesensory, the potential market volume for this product could reach thousands of units per year worldwide.
Nomad integrates Microvision's patented retinal scanning display (RSD) technology into head worn devices. The technology scans a low-power beam of light to "paint" rows of pixels onto the eye, creating a high resolution, see-through, full-motion image without the use of electronic screens of any kind (see Microvision's Non-invasive Approach May Aid Disease Screening -- Medical Researchers Eye Apps For Retinal Displays.)
Telesensory's initial focus is on those people afflicted with age related macular degeneration (AMD). The system could also prove useful as a reading system for people with glaucoma, diabetic retinopathy or retinitis pigmentosa (RP).
Ann Wojcicki, who sat next to her husband during the Gavin Newsom interview, was honored at the below event. This was the first time Google Glass was seen "in the wild". Would Brin have chosen this event if Google Glass could not be used by those affected by vision-robbing conditions?
Foundation Fighting Blindness to Host San Francisco Dining in the Dark in Support of Research
23andMe CEO and Genentech Global Head of Ophthalmology to Be Honored with Visionary Awards
San Francisco, CA (March 8, 2012) — The Foundation Fighting Blindness, a national nonprofit focused on driving sight-saving research, will honor Anne Wojcicki, CEO and co-founder, 23andMe, and Anthony P. Adamis, M.D., vice president, global head of ophthalmology, Genentech, Inc., at the San Francisco Dining in the Dark Visionary Awards Dinner. The event, happening Thursday, April 5, at the historic Palace Hotel, will raise critical research funds toward preventions, treatments and cures for vision-robbing retinal degenerative diseases like macular degeneration, retinitis pigmentosa (RP), Usher syndrome, and related conditions.
Sentiment: Strong Buy
drsteven51 is a key player in this pump and dump.
Hahahaha, yes! But its early in the 1st gtr. The underdog team has been here before...and that's why they play the game..
place your bets gentlemen...😊
First the badgers complain because the reports from MJNA was late in their minds and now they complain they do hear from them. Rediculous. MJNA is the premier thriving and expanding hemp and canna company.
Sentiment: Strong Buy
please psot info.
Sentiment: Strong Buy
drowning in gold
With dips I know they are false dips based on hype not how the company is doing. The drug war is almost over folks. You have to decide for yourself if you want to finish smiling with facts or bickering. I choose the fiorner. We are all in this together, can we not work together to end this war peacefully? We can all win in the end. MJNA is a profitable company enduring attacks by ant drug groups and opportunists. Lets work together. Either buy and hold this stock or at least stop the bickering. The future is bright . Lets work together peacefully and support this thriving growing company
Sentiment: Strong Buy
It's a matter of odds...i like gambling
Sentiment: Strong Buy
Thanks for your response. But isnt it outdated? It doesnt mention the focus on cost control to drastically lower breakeven point. and the subsequent focus on organic growth (eg targeted promotions such as the new prizes for botlecaps).
Do your own research and invest.They want to take away your hard earned money.
WHAT A WASTE OF TIME THIS BOARD IS
I know I have seen this somewhere. It makes sense. What about using Fusilev for treating Crohn's disease. Chemo therapy has been used in the past to treat it. Now, Remicade is the drug of choice At least it is for my doctor since he did all the work on it. Could have used some myself for the last four days, but with all the potent and/or toxic drugs used to save my eye and brain, no way. But when I am better, I will get back to you..
what will we see
Sentiment: Hold
That was my impression as well.
Didn't move the stock price a cent. It's like a vise grip, in a low volume setting.
Something's gotta give sooner or later.
Top, I see you don't see the future value in Rexahn. I don't understand how much you understand MDD either and being involved in the health care sector doesn't prove anything. Why you speak for Red? He cannot speak for himself. This is more ridiculous to me. Good luck with your investing!
Sentiment: Strong Buy
The idiot pumper are exhausted as most longs are
shorts rule this little piggy
ouch 2.89s open